Sennosides
Sennosides is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| assured natural laxative | OTC monograph not final | 2016-07-28 |
| bekunis natures gentle laxative herbal tea | OTC monograph not final | 2011-03-24 |
| bekunis natures gentle laxative instant tea | OTC monograph not final | 2011-03-21 |
| bekunis natures gentle stimulant laxative | OTC monograph not final | 2011-02-13 |
| best choice senna | OTC monograph final | 2012-11-08 |
| careall sennosides | C200263 | 2024-01-29 |
| caremotion | OTC monograph not final | 2021-11-18 |
| chocolate laxative | C200263 | 2024-12-23 |
| chocolated laxative | C200263 | 2024-12-23 |
| chupanzon colon detox | C200263 | 2023-11-16 |
Show 94 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
42 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Constipation | D003248 | — | K59.0 | — | 2 | 4 | 6 | 5 | 16 |
| Opioid-induced constipation | D000079689 | — | — | — | — | — | 1 | 2 | 3 |
| Colorectal neoplasms | D015179 | — | — | — | — | — | 1 | 1 | 2 |
| Analgesia | D000698 | — | — | — | — | — | 1 | — | 1 |
| Pain | D010146 | EFO_0003843 | R52 | — | — | — | 1 | — | 1 |
| Lower urinary tract symptoms | D059411 | EFO_0008008 | — | — | — | — | 1 | — | 1 |
| Paralysis | D010243 | — | — | — | — | — | 1 | — | 1 |
| Neoplasms | D009369 | — | C80 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Inflammatory bowel diseases | D015212 | EFO_0003767 | — | — | — | 1 | — | 1 | 2 |
| Colonoscopy | D003113 | — | — | — | 1 | 1 | — | 1 | 2 |
| Fistula | D005402 | — | — | — | — | 2 | — | — | 2 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | — | 1 | — | — | 1 |
| Obstructive lung diseases | D008173 | — | — | — | — | 1 | — | — | 1 |
| Dyspnea | D004417 | — | R06.0 | — | — | 1 | — | — | 1 |
| Rectal neoplasms | D012004 | — | — | — | — | 1 | — | — | 1 |
| Colonic neoplasms | D003110 | — | C18 | — | — | 1 | — | — | 1 |
| Hemorrhage | D006470 | MP_0001914 | R58 | — | — | 1 | — | — | 1 |
| Anemia | D000740 | EFO_0004272 | D64.9 | — | — | 1 | — | — | 1 |
Show 3 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Gastroparesis | D018589 | EFO_1000948 | K31.84 | — | 1 | — | — | — | 1 |
| Gastrointestinal diseases | D005767 | — | — | — | 1 | — | — | — | 1 |
| Digestive system diseases | D004066 | EFO_0000405 | K92.9 | — | 1 | — | — | — | 1 |
| Healthy volunteers/patients | — | — | — | 1 | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obesity | D009765 | EFO_0001073 | E66.9 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Fecal incontinence | D005242 | — | R15 | — | — | — | — | 2 | 2 |
| Necrotizing enterocolitis | D020345 | EFO_0003928 | K55.3 | — | — | — | — | 1 | 1 |
| Intestinal obstruction | D007415 | — | K56.60 | — | — | — | — | 1 | 1 |
| Elective surgical procedures | D017558 | — | — | — | — | — | — | 1 | 1 |
| Enterocolitis | D004760 | EFO_1001481 | — | — | — | — | — | 1 | 1 |
| Hirschsprung disease | D006627 | EFO_0004241 | Q43.1 | — | — | — | — | 1 | 1 |
| Colostomy | D003125 | — | — | — | — | — | — | 1 | 1 |
| Meconium ileus | D000074270 | — | P76.0 | — | — | — | — | 1 | 1 |
| Encopresis | D004688 | — | F98.1 | — | — | — | — | 1 | 1 |
| Autistic disorder | D001321 | EFO_0003758 | F84.0 | — | — | — | — | 1 | 1 |
Show 9 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Sennosides |
| INN | — |
| Description | Senna glycoside, also known as sennoside or senna, is a medication used to treat constipation and empty the large intestine before surgery. The medication is taken by mouth or via the rectum. It typically begins working in around 30 minutes when given by rectum and within twelve hours when given by mouth. It is a weaker laxative than bisacodyl and castor oil.
|
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL2108559 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | DB11365 |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
3,774 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use